According to Axsome Therapeutics 's latest financial reports the company's current earnings are HK$0.33 Billion. In 2023 the company made an earning of -HK$1.86 Billion a decrease over its 2022 earnings that were of -HK$1.46 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2024 (TTM) | -HK$2.43 Billion | 31.22% |
2023 | -HK$1.86 Billion | 27.33% |
2022 | -HK$1.46 Billion | 43.5% |
2021 | -HK$1.02 Billion | 26.73% |
2020 | -HK$0.8 Billion | 50.56% |
2019 | -HK$0.54 Billion | 120.71% |
2018 | -HK$0.25 Billion | 6.99% |
2017 | -HK$0.23 Billion | 6.4% |
2016 | -HK$0.22 Billion | 157.6% |
2015 | -HK$82.07 Million |